Literature DB >> 8442421

Audiological assessment of eleven congenital hypothyroid infants before and after treatment.

M François1, P Bonfils, J Leger, P Avan, P Czernichow, P Narcy.   

Abstract

Eleven congenital hypothyroid newborns were consecutively referred for audiological evaluation before any treatment. Evoked otoacoustic emissions were present bilaterally in 9 newborns. These results suggest the normality outer hair cells and contrast with results obtained in experimental studies. The auditory brainstem responses in 6 newborns showed a prolonged wave I, as previously reported by other authors. At 9 to 12 months of age, all children treated had evoked otoacoustic emissions in at least one ear. In 9 cases, the auditory threshold was normal (equal to or below 20 dB) as determined by behavioural tests.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442421     DOI: 10.3109/00016489309135764

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  Audiological Evaluation in Hypothyroid Patients and Effect of Thyroxine Replacement Therapy.

Authors:  Ramsiya Singh; Mohd Aftab; Sachin Jain; Dinesh Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-14

Review 2.  Congenital Hypothyroidism and the Deleterious Effects on Auditory Function and Language Skills: A Narrative Review.

Authors:  Caio Leônidas Oliveira Andrade; Crésio de Aragão Dantas Alves; Helton Estrela Ramos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-10       Impact factor: 5.555

3.  Lipomatous myelomeningocele, athyrotic hypothyroidism, and sensorineural deafness: a new form of syndromal deafness?

Authors:  H L Peters; A Bankier
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

4.  Hearing impairment in congenitally hypothyroid patients.

Authors:  Mahin Hashemipour; Silva Hovsepian; Mostafa Hashemi; Massoud Amini; Roya Kelishadi; Somaye Sadeghi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.